Dr. Marco Gambacciani, M.D. Joins Bionovo, Inc. Medical Advisory BoardBionovo, Inc. (Nasdaq: BNVI) announced today the appointment of European menopause expert, Marco Gambacciani, M.D., to the company's Medical Advisory Board. Dr. Gambacciani is Professor of Obstetrics and Gynecology and Director of the Menopause Research Clinic at the Santa Chiara University Hospital in Pisa, Italy.
"We are honored to have Dr. Gambacciani join our Medical Advisory Board given his well established expertise and publication record in the field of menopause research. We are eager to work closely with Dr. Gambacciani to advance Menerba(TM) through Phase 3 clinical testing in Europe. With Dr. Gambacciani's assistance, we will seek European Medicines Agency (EMEA) regulatory approval for our drug development pathway of Menerba," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.
Dr. Gambacciani stated, "It is very exciting to participate in the late stage clinical development of Menerba for the treatment of menopausal symptoms. Bionovo's novel selective estrogen receptor beta agonist has shown great promise in Phase 2 clinical testing to effectively treat hot flashes and Menerba's safety profile appears superior to currently available hormone therapies. I am eager to launch clinical testing in Europe and believe, if approved, Menerba will be in great demand by women seeking a safe and effective treatment for hot flashes."
Dr. Gambacciani graduated in 1978 from the University of Pisa and finished his residency in Obstetrics and Gynecology in 1982. In 1986 he completed his Postdoctoral Fellowship in Reproductive Endocrinology at the Department of Reproductive Medicine, University of California, San Diego. Since 1987, he has been serving as the Director of the Menopause Research Clinic at the Santa Chiara University Hospital in Pisa.
Dr Gambacciani is also a member of numerous national and international professional societies and he has served as a Member of the Executive Committee of the International Menopause Society. Dr Gambacciani is currently a Member of the Executive Committee of the European Menopause and Andropause Society. He has been a guest faculty member, invited speaker, visiting professor and course director worldwide at many prestigious institutions. He is author of over 120 papers published in peer reviewed international journals. Dr Gambacciani's clinical and research focus includes various aspect of gynecological endocrinology, contraception, biology of menopause and perimenopause, and osteoporosis as well as the risks and benefits associated with the use of estrogen-based therapies.